46 22 9 11 Update 46-1 Gd-EOB-DTPA MRI EOB-MRI HCC dysplastic nodule DN 146 62 146 123 HCC 23 DN B hypoechoic 67 46%hyperechoic 79 54% bright loop 14% A dynamic MDCT iso density EOB-MRI 24 B CT low density 122 B A/B hypoechoic 75%/40%, hyperechoic 25%/60% P=0.001 MRI T1 A 6 25% B 69 57% P=0.004 EOB-MRI B 46-2 CTHA/CTAP 79 C CT MRI S4 4cm CTHA CTAP EOB-MRI TIWI T2WI Sonazoid US hypo echoic 30 2 iso echoic post vascular phase defect S4 US 46-3 planning sonography RVSCEUS 43 52 1. 2. RVS CEUS 3. 1. 1 23 4 2. good 9 fair 28 poor 12 invisible 3 good RVS fair poor invisible RVS CEUS 3. 96.2% 7.7% RVS CEUS 46-4 Sonazoid Sonazoid Sonazoid 15 Mechanical Index:0.2 focus TIC Sonazoid 0.010ml/kg TIC 25 39.5, 2.5-81.5 PT BMI Spleen Index Sonazoid 46-5 Sonazoid 70 2004 2009 8 10 CT 80mm
CT MRI Sonazoid 46-6 Sonazoid 70 B CT EOB-MRI Sonazoid Vascular phase Post-vascular phase Re-injection 6 5HIAA 46-7 Sonazoid DIC B Sonazoid CEUS 4 4 3 defect 1 defect B Sonazoid CEUS 46-8 10mm FNH 3 10mm FNH 40 51 73 3 CT S4 S5 S4 8-10mm B 3 central satellite scar spoke wheel appearance Sonazoid early arterial phase spoke wheel appearance late vascular phase Kupffer phase FNH HCC size FNH 46-9 1 70 H21 5 H22 6 CT Sonazoid 4 3500 ml 5%EOI Hct 5.9% 46-10 70 C 2009 4 AFP PIVKA 4 SOL 3 HCC S2 S2 10 US 12 CT 2010 4 US S2 S2 halo Sonazoid S2 S2 S2 HCC 46-11 1 85 spleen index 9.5 4.0 5cm CT
2cm 21G 46-12 73 PBC 22 2 S8 16mm Sonazoid early vascular phase late vascular phase Kupffer phase color doppler vascular phase penetrating vessel non-hodgkin lymphoma low grade B-cell lymphomapbc color doppler 46-13 1 70 17 CT MRI hypovascular metastasis color Doppler 15 metastasis retrospective review B-mode color Doppler hypervascular CT MRI 46-14 81 CT MRCP T-Bil3.7mg/dl ERCP EUS US hypovascular tumor EUSFNA 46-15 1 60 US US US CT MRI ERCP 50% IgG4 IgG4 / 46-16 EUS-FNA 1 46 LDH IgG US CT MRI DWI EUS capsule like rim ERCP EUS-FNA PET-CT FDG Burkitt lymphoma 46-17 80
DIC-CT 15mm EUS 2cm. 2cm 1 46-18 ss 76 US 8mm 14mm EUS 46-19 22 C 132 FibroScan Child Pugh Child Pugh P3P4 7s 46-20 C C C 3 C 55 0 1 23 4 FibroScan KPa HCV 5 46-21 AdaBoost 12 8 Cross-Validation 56% 85% 46-22 Virtual touch tissue quantification Virtual touch tissue quantification VTTQ (FIB4-index APRI 2009 1 2010 5 VTTQ 105 59 25-89 / 57/48 HBV/HCV 26/79 F cut off AUROC VTTQ; F1/2:1.195 0.875 0.8360.871 F2/3;1.565 0.938 0.9170.938 F3/4; 1.775 0.898 0.8570.961 FIB4;F1/2:17.13(0.750 0.7810.689 F2/3:28.16 0.716 0.542 0.689 F3/4:46.7(0.691 0.5710.651 APRI;F1/2:5.635 0.719 0.749 0.718 F2/3:9.93(0.691 0.6250.718 F3/4:11.17 0.728 0.542
0.552 VTTQ VTTQ 46-23 C C C 66 TOSHIBA APLIO XG F -3, A1-3 HARI, HAPI, SARI, SAPI, PVVmean Alb AST ALT -GTP, PLT SAPI SARI SAPI AST ALT AST ALT Update 46-24 EUS ESD EMR, ESD EUS 16 4 21 3 EMR,ESD387 202 52 51 98.1% 105 101 96.2% 13 3 23.1% 9 69.2% EMR, ESD 46-25 1 m sm1 4 13 17 3 75% 4 31% 3 75% 3 23% 46-26 EUS EUS 366 3 m 1mm sm 1mm m/sm EUS-m m/sm sm AD EUS-m 80.8% 194/240 EUS-sm 57.1% 28/49 8 EUS-m/sm 80.0% m 20.0% sm EUS 46-27 2009.4 2010.6 mp se n=33 mp 4 5 ss 5 ss 5 se ss 5
46-28 48 CT free air 5 US 30mm 46-29 52 SMA cm SMA SMA sandwich sign Castleman CT PET/CT 200cm 50cm myofibroblast 46-30 1 80 CT MRI CT 46-31 3 3 7 3 3 8 S 2cm 1 2cm 46-32 35 2009 12 X 8 8 40 US S US 20 / 3 US US S - US S 4 8 46-33
46-34 US EUS Sonazoid US EUS US 2007 6-2010 4 EUS 2009 10-2010 4 FNA 6 38 18 17 IPMN 14 mucus debris 1 NET 2 SPN 1 2 Sonazoid IPMN 46-35 58 19 15mm CT,MRI EUS-FNA 9 3 4cm CT Sonazoid EUS-FNA 46-36 IPMN 70 45mm 8.5mm 3 9 MRI Sonazoid 15mm ERCP ENPD IPMC 46-37 3D paillary fibroelastoma 72 Debakey 7 2002 21 9,,aVF ST 2D flap CT STEMI 100% flow flow 3D 10mm 3D paillary fibroelastoma 46-38 50 2004 12 4mm 2009 8 P2 13 10mm 46-39 61 21 6
3D 46-40 45 adenocarcinoma PET-CT FDG isoechoic 16 10mm 4 12 PET-CT 30 46-41 34 RT area trace 70 80% PSV peak systolic velocity 2.5m/s 1.7m/s 80% PSV 4.6m/s 3.6m/s 46-42 60 16 2009 3 6 Cr Cr 6.3mg/dl PSV 90% PTA PSV Cr 8 1.3mg/dl PTA 12 Cr 1.3mg/dl 46-43 MRA 3DCT 46-44 2D 45 22 5 1 2D dyssynchrony post systolic shortning 90% 2D 46-45 14 2
2 2 14 1 8,650/mm3 65%CRP 1.83mg/dl ESR 43/71 2 1 CRP 3 7mg/dl CT 46-46 28 H22 4 X effusion Myeloid/NK-cell acute leukemia effusion 46-47 18 67 21 8 X CT A-aDO2 46-48 spontaneous echo contrast spontaneous echo contrast 1 9 spontaneous echo contrast spontaneous echo contrast spontaneous echo contrast spontaneous echo contrast 46-49 15 1 55 15 CPA XP shuffle motion 46-50 Tei index Tei index 95%ile 12 2 4 3 1 3 1 1 Tei index 2 46-51 congenital absence of the portal vein: CAPV
26 16 CAPV 25 27 4 CAPV 1031g AS5/7 CAPV 46-52 3 three vessel view 3 38 11 2 39 PGE1 17 BT 22q11.2 3 trisomy21 37 NICU trisomy21 20 46-53 90% NICU 9 46-54 3 3 1 37 1 1 33 0 33 2 1704 g Apgar79 2 37 1 0 33 3 36 6 2332 g Apgar8/9 3 32 1 0 27 33 1 37 1 2618 g Apgar Score8/9 46-55 congenital pouch colon congenital pouch colon pouch colon 31 30 0 20 34 4 2321 g 1 1 5 5 ph 7.417 40 20 46-56 38 3 2 19 24 AFI 35cm 29 20ml/h 4 6500ml 33 1 3400g AS 1/5 Zimmerman-Laband 46-57 1 1
18 25 29 30 32 3 32 4 NST 3 46-58 34 21 5cm Tei index 28 35 4242g As 1/3 Hb3.5mg/dl 4 18 16 15cm 46-59 31 27 2 31 4 34 2 2,500ml 46-60 34 39 MTX 20 1 46-61 HCCRFA B-mode RFA CT margin B-mode Sonazoid RFA B-mode HCC TOSHIBA medical Aplio mode Sonazoid RFA CT CT RFA 1 RFA 46-62 1 60 2009 10 S8 15mm 1 RFA Sonazoid RFA 10ml 2 4 RFA 46-63 1 74 CT S4 35 US 21G Majima needle Debris CT CT
4 US CT 5 US 0.0059% US US 46-64 2008 12 6 VAS CT 15-20ml 2 46-65 2002 25 27 1 1 79mm 38-120mm GF-UCT240-AL5 Echotip Wilson Cook 19G EUS 14 96% 26/27 15% 4/27 4% 1/27 2 46-66 Carotidynia Carotidynia Carotidynia 1927 Fay 1967 Roseman 1988 the International Headache Society IHS classification committee 2004 Giant cell arteritis Carotidynia Carotidynia 46-67 1 50 30 46-68 RVS US 3D CT-lymphography SLN Real-time virtual sonography RVS US CT SLN US SLN US SLN ICG SLN SLN 137 136 99% ICG SLN 9 ICG SLN US SLN SLN SLN SLN 46-69 2 2 1 83 2 20mm 2 47 1
20mm 2 46-70 1 5 4 2.0cm 2.0cm CT MRI T1WI T2WI 46-71 1 20 3 16 IU/m FNAC classiv 46-72 1 30 CT 15 CT MRI 46-73 AVM AVM CT MRI AVM CT MRI AVM